The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Up-regulation of Caveolae and Caveolar Constituents in Multidrug-resistant Cancer Cells
Open accessAbstract
Cancer chemotherapy often results in the development of multidrug resistance (MDR), which is commonly associated with overexpression of P-glycoprotein (P-gp), a plasma membrane drug efflux ATPase. It was shown recently that glycosphingolipids are elevated in MDR cells. Sphingolipids are major constituents of caveolae and of detergent-insoluble, glycosphingolipid-rich membrane domains. Here we report that multidrug-resistant HT-29 human colon adenocarcinoma cells exhibit a 12-fold overexpression of caveolin-1, a 21-kDa coat/adaptor protein of caveolae. Similar observations were made in adriamycin-resistant MCF-7 human breast adenocarcinoma cells. Caveolin-2 expression is also up-regulated in MCF-7-AdrR cells, but neither caveolin-1 nor caveolin-2 were detected in MCF-7 cells stably transfected with P-gp. The up-regulation of caveolins is associated with a 5-fold increase in the number of caveolae-like structures observed in plasma membrane profiles of HT-29-MDR cells and with the appearance of a comparable number of caveolae in MCF-7-AdrR cells. A significant fraction (approximately 40%) of cellular P-gp is localized in low density detergent-insoluble membrane fractions derived from either HT-29-MDR or MCF-7-AdrR cells. The distribution of recombinant P-gp in stably transfected MCF-7 cells was similar, even though these cells do not express caveolins and are devoid of caveolae. The possibility that caveolae contribute to the multidrug resistance and thus are co-selected with P-gp during the acquisition of this phenotype is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Characterization of a Cytosolic Heat-shock Protein-Caveolin Chaperone Complex
Uittenbogaard, A., Ying, Y.-S., & Smart, E. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6525 · Cited by 301
RetractedMarkwell, M. A. K., Haas, S. M., Bieber, L. L., & Tolbert, N. E. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90586-9 · Cited by 6,458
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Brown, D. A., & Rose, J. K. (1992) · Cell · doi:10.1016/0092-8674(92)90189-j · Cited by 2,921
Caveolin, a protein component of caveolae membrane coats
Rothberg, K. G., Heuser, J. E., Donzell, W. C., Ying, Y.-S., Glenney, J. R., & Anderson, R. G. W. (1992) · Cell · doi:10.1016/0092-8674(92)90143-z · Cited by 2,258
Okamoto, T., Schlegel, A., Scherer, P. E., & Lisanti, M. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5419 · Cited by 1,498
Schnitzer, J. E., Oh, P., Pinney, E., & Allard, J. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.5.1217 · Cited by 919
Caveolae, DIGs, and the dynamics of sphingolipid—cholesterol microdomains
Harder, T., & Simons, K. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80030-0 · Cited by 779
De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin.
Fra, A. M., Williamson, E., Simons, K., & Parton, R. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8655 · Cited by 596
Identification, sequence, and expression of caveolin-2 defines a caveolin gene family.
Scherer, P. E., Okamoto, T., Chun, M., Nishimoto, I., Lodish, H. F., & Lisanti, M. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.131 · Cited by 561
Parton, R. G. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80033-0 · Cited by 549
Cell-type and Tissue-specific Expression of Caveolin-2
Scherer, P. E., Lewis, R. Y., Volonté, D., Engelman, J. A., Galbiati, F., Couet, J., Kohtz, D. S., van Donselaar, E., Peters, P., & Lisanti, M. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.29337 · Cited by 526
A Role for Caveolin in Transport of Cholesterol from Endoplasmic Reticulum to Plasma Membrane
Smart, E. J., Ying, Y.-S., Donzell, W. C., & Anderson, R. G. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29427 · Cited by 501
Reduction of caveolin and caveolae in oncogenically transformed cells.
Koleske, A. J., Baltimore, D., & Lisanti, M. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1381 · Cited by 499
Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells
Lee, S. W., Reimer, C. L., Oh, P., Campbell, D. B., & Schnitzer, J. E. (1998) · Oncogene · doi:10.1038/sj.onc.1201661 · Cited by 421
Engelman, J. A., Wykoff, C. C., Yasuhara, S., Song, K. S., Okamoto, T., & Lisanti, M. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16374 · Cited by 369
How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture.
Gottesman, M. M. (1993) · PubMed · Cited by 352
Accumulation of Glucosylceramides in Multidrug-resistant Cancer Cells
Lavie, Y., Cao, H.-T., Bursten, S. L., Giuliano, A. E., & Cabot, M. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19530 · Cited by 340
Self-citationParton, R. G., & Simons, K. (1995) · Science · doi:10.1126/science.7660120 · Cited by 315
Caveolin-1 and -2 in the Exocytic Pathway of MDCK Cells
Scheiffele, P., Verkade, P., Fra, A. M., Virta, H., Simons, K., & Ikonen, E. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.4.795 · Cited by 302
Fairchild, C. R., Ivy, S. P., Kao-Shan, C. S., et al. (1987) · PubMed · Cited by 297
Intracellular cholesterol transport
Fielding, C. J., & Fielding, P. E. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37169-8 · Cited by 289
Plasma membrane caveolae mediate the efflux of cellular free cholesterol
Fielding, P. E., & Fielding, C. J. (1995) · Biochemistry · doi:10.1021/bi00044a004 · Cited by 276
Bist, A., Fielding, P. E., & Fielding, C. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10693 · Cited by 253
Tran, D., Carpentier, J. L., Sawano, F., Gorden, P., & Orci, L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.22.7957 · Cited by 250
Fielding, C. J., Bist, A., & Fielding, P. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3753 · Cited by 239
Caveolae, transmembrane signalling and cellular transformation
Lisanti, M. P., Tang, Z., Scherer, P. E., Kübler, E., Koleske, A. J., & Sargiacomo, M. (1995) · Molecular Membrane Biology · doi:10.3109/09687689509038506 · Cited by 156
RNA Genetics of Breast Cancer: Maspin as ParadigmPreprint
Sager, R., Sheng, S., Anisowicz, A., Sotiropoulou, G., Zou, Z., Stenman, G., Swisshelm, K. L., Chen, Z., Hendrix, M. J. C., Pemberton, P. A., et al. (1994) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1994.059.01.060 · Cited by 122
Lisanti, M. P., Tang, Z., Scherer, P. E., & Sargiacomo, M. (1995) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(95)50103-7 · Cited by 120
Role of Multidrug Resistance P-glycoproteins in Cholesterol Biosynthesis
Metherall, J. E., Li, H., & Waugh, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.5.2634 · Cited by 109
Fairchild, C. R., Moscow, J. A., O’Brien, E., et al. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11028-6 · Cited by 107
Dimitroulakos, J., & Yeger, H. (1996) · Nature Medicine · doi:10.1038/nm0396-326 · Cited by 104
Fielding, P. E., & Fielding, C. J. (1996) · Biochemistry · doi:10.1021/bi9613382 · Cited by 97
Progesterone Inhibits Cholesterol Biosynthesis in Cultured Cells
Metherall, J. E., Waugh, K., & Li, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.5.2627 · Cited by 92
Induction of multidrug resistance downregulates the expression of CFTR in colon epithelial cells
Breuer, W., Slotki, I. N., Ausiello, D. A., & Cabantchik, I. Z. (1993) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1993.265.6.c1711 · Cited by 58
Holmberg, M., Sandberg, C., Nygren, P., & Larsson, R. L. (1994) · Anti-Cancer Drugs · doi:10.1097/00001813-199410000-00012 · Cited by 29
Cited by
Role of Caveolae and Caveolins in Health and Disease
Cohen, A. W., Hnasko, R., Schubert, W., & Lisanti, M. P. (2004) · Physiological Reviews · doi:10.1152/physrev.00046.2003 · Cited by 893
Taron, M., Ichinose, Y., Rosell, R., Mok, T., Massuti, B., Zamora, L., Mate, J. L., Manegold, C., Ono, M., Queralt, C., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2618 · Cited by 334
Multiple physiological functions for multidrug transporter P-glycoprotein?
JOHNSTONE, R., RUEFLI, A., & SMYTH, M. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01493-0 · Cited by 309
Caveolin-1 and Cancer Metabolism in the Tumor Microenvironment: Markers, Models, and Mechanisms
Sotgia, F., Martinez-Outschoorn, U. E., Howell, A., Pestell, R. G., Pavlides, S., & Lisanti, M. P. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-120856 · Cited by 281
Domains and Rafts in Lipid Membranes
Binder, W. H., Barragan, V., & Menger, F. M. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200300586 · Cited by 276
Metadata
- Authors
- Lavie, Y., Fiucci, G., & Liscovitch, M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1998-12
- Volume
- 273
- Issue
- 49
- Pages
- 32380-32383
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2049349156
- Cited by
- 294
- References
- 36
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.